Zealand Pharma A/S | Mutual Funds
Mutual Funds that own Zealand Pharma A/S
Royce Value Trust
408,857
1.33%
0
0.37%
06/30/2018
Fidelity Select Biotechnology Portfolio
400,644
1.3%
0
0.06%
07/31/2018
305,000
0.99%
-25,000
0.99%
03/31/2018
TETON Westwood Mighty Mites Fund
300,000
0.98%
0
0.28%
06/30/2018
BIL Nordic Invest - Danske Small Cap Aktier
264,291
0.86%
264,291
4.42%
06/30/2017
Royce Pennsylvania Mutual Fund
213,372
0.69%
51,100
0.14%
06/30/2018
Royce Micro Cap Trust
187,900
0.61%
0
0.59%
06/30/2018
Government Pension Fund - Global (The)
186,605
0.61%
16,802
0%
12/31/2017
Kokusai Global Healthcare & Bio Open Mother Fund
174,441
0.56%
174,441
0.1%
08/28/2017
Royce Low Priced Stock Fund
151,300
0.49%
30,700
0.77%
06/30/2018
| Address |
Smedeland 36
Glostrup ZE 2600
Denmark
|
|
Employees
|
- |
| Website |
http://www.zealandpharma.com |
| Updated |
07/08/2019 |
| Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark. |
